Drug Pipeline

PDR001 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05201066 Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab… Myelodysplastic Syndromes Active, Not Recruiting
Phase 1
NCT03891953 Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT03961971 Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM Glioblastoma Multiforme Active, Not Recruiting
Sponsors Running PDR001 Trials
Novartis Pharmaceuticals (2) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Colorectal Cancer (1) Melanoma (1) Glioblastoma (1) Leukemia (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when PDR001 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free